ABBV FY 2010 Earnings Report — AbbVie Inc. Revenue & Financial Results | Market Cap Arena

AbbVie Inc.ABBV

FY 2010 Earnings

Reported December 31, 2010

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2010	Prior Q	FY 2009	QoQ Change	YoY Change
Revenue	$15.6B	—	$14.2B	—	10.0%
Op. Income	$4.7B	—	$4.9B	—	-4.4%
Gross Margin	72.5%	—	71.5%	—	1.1pp
Net Margin	26.7%	—	32.6%	—	-5.9pp
EPS (Diluted)	$2.57	—	$2.85	—	-9.8%
Free Cash Flow	$4.5B	—	$5.1B	—	-10.4%

Revenue Flow

Item	Amount
REVENUE	$15.6B
Cost of Revenue	$4.3B
GROSS PROFIT	$11.3B
R&D Expenses	$2.8B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$3.8B
Other Expenses	$0
Operating Expenses	$6.6B
Cost & Expenses	$10.9B
OPERATING INCOME	$4.7B
Interest Income	$28M
Interest Expense	$0
Other Income/Expenses	$119M
INCOME BEFORE TAX	$4.8B
Income Tax Expense	$658M
Net Income from Continuing Ops	$4.2B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$4.2B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$4.2B
D&A	$1.2B
EBIT	$4.8B
EBITDA	$6.0B
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$15.6B
Cost of Revenue	$4.3B
GROSS PROFIT	$11.3B
R&D Expenses	$2.8B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$3.8B
Other Expenses	$0
Operating Expenses	$6.6B
Cost & Expenses	$10.9B
OPERATING INCOME	$4.7B
Interest Income	$28M
Interest Expense	$0
Other Income/Expenses	$119M
INCOME BEFORE TAX	$4.8B
Income Tax Expense	$658M
Net Income from Continuing Ops	$4.2B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$4.2B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$4.2B
D&A	$1.2B
EBIT	$4.8B
EBITDA	$6.0B
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$4.2B
Depreciation & Amortization	$1.2B
Stock-Based Compensation	$167M
Deferred Income Tax	$0
Other Non-Cash Items	$313M
Change in Working Capital	-$866M
OPERATING CASH FLOW	$5.0B
Capital Expenditure	-$448M
Acquisitions (Net)	-$2.6B
Purchases of Investments	-$93M
Sales/Maturities of Investments	$1M
Other Investing Activities	-$1.9B
NET CASH FROM INVESTING	-$5.0B
Net Debt Issuance	$0
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$65M
NET CASH FROM FINANCING	$65M
FREE CASH FLOW	$4.5B
Net Change in Cash	$65M

Balance Sheet

Item	Amount
Cash & Equivalents	$10M
Short-Term Investments	$1M
Net Receivables	$3.4B
Inventory	$836M
Other Current Assets	$3.5B
TOTAL CURRENT ASSETS	$8.2B
PP&E (Net)	$2.4B
Goodwill	$6.2B
Intangible Assets	$3.7B
Long-Term Investments	$137M
Tax Assets	$533M
Other Non-Current Assets	$0
TOTAL NON-CURRENT ASSETS	$12.9B
TOTAL ASSETS	$21.1B
Account Payables	$357M
Short-Term Debt	$0
Deferred Revenue	$0
Other Current Liabilities	$3.0B
TOTAL CURRENT LIABILITIES	$3.8B
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$485M
Other Non-Current Liabilities	$1.2B
TOTAL NON-CURRENT LIABILITIES	$1.7B
TOTAL LIABILITIES	$5.4B
Common Stock	$0
Additional Paid-In Capital	$0
Retained Earnings	$0
Treasury Stock	$0
Accum. Other Comp. Income	$288M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$15.7B
Minority Interest	$0
TOTAL EQUITY	$15.7B
TOTAL LIABILITIES & EQUITY	$21.1B
Total Debt	$0
Net Debt	-$1.9B